or no inflammatory infiltrates. [2] [3] [4] Our patient fulfilled the diagnostic criteria for the diagnosis of acute inflammatory autoimmune myopathy.
Proximal muscle weakness occurs, along with neck flexor, pharyngeal, and respiratory muscle involvement. [2, 4] Other manifestations include fatigue, weight loss, and dysphagia. [2] [3] [4] Dyspnea and neuromuscular respiratory weakness are described in 33% of the cases. [2, 4] Interstitial lung disease and cardiac involvement have been reported. [2, 4] These abnormalities are reversed with immunosuppressive treatment. [5] Laboratory evaluation discloses high levels of CK with myopathic findings on electromyography. [1, 2, 4] STIR images show abundant edema in the musclofascial planes, a finding which is characteristic of this disease (edema sign). On pathologic examination, muscle fibers are necrotic with a pauciimmune inflammatory infiltrate and infiltration with histiocytes. [1] [2] [3] The cause for acute necrotizing myopathy is multifactorial. [2] [3] [4] Fifty percent of the patients have no identifiable risk factors. [2] [3] [4] Anti-SRP antibody has been described as a marker of ANM, especially when related to the use of statins. [2, 4] The course is often self-limiting and recovery occurs following treatment with intravenous or oral steroids and immunosuppressants such as mycophenolate mofetil or rituximab. [2, 5] Reviewing the literature, ANM is a very rare disease. [1, 4] In this communication, we have highlighted the salient features of this eminently treatable condition.
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There are no conflicts of interest. Sir, I went through the article entitled "Vitamin D as a marker of cognitive decline in elderly Indian population" published in 'Annals of Indian Academy of Neurology' (2015; 18:314-9) with interest. [1] Reports in the past have reflected on the widespread prevalence (50-90%) of vitamin D deficiency and its role as a risk factor for various health problems. [2] Keeping this in view, the study is an important addition to the published literature on health problems due to vitamin D deficiency. The authors deserve credit for this. However, I have a few points of concern with the study. The authors in their section on
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material and methods write that "The study population was divided into three groups; viz., patients suffering from AD and vascular dementia as well as patients with vascular cognitive impairment (VCI) not amounting to dementia (Group A, n = 32), patients with MCI (Group B, n = 24), and elderly agematched controls (Group C, n = 30)." This statement seems a bit confusing as patients suffering from Alzheimer's disease (AD) and vascular dementia as well as patients with VCI not amounting to dementia have been grouped together as if they both mean the same. Also, in the analysis part, this group has been referred to as the "dementia" group only.
